glp-1 agonists addiction Anti-Obesity Rx and Alcohol and Substance Use Disorders Glucagon-like peptide-1 receptor: mechanisms and
Description
Preclinical studies suggest that GIPR antagonism helps with weight loss and metabolic improvements
Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality
The heatmap below illustrates how side effects differ across GLP-1 drugs, offering a snapshot of how people experience their GLP-1 medication in everyday life
As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses
Learn how this impacts injury risk, recovery, and long-term function.
